Exact Mass: 346.0841

Exact Mass Matches: 346.0841

Found 14 metabolites which its exact mass value is equals to given mass value 346.0841, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

3-O-Methylfluorescein

3-hydroxy-6-methoxy-3H-spiro[2-benzofuran-1,9-xanthene]-3-one

C21H14O5 (346.0841)


   

Raclopride

3,5-Dichloro-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-hydroxy-6-methoxybenzene-1-carboximidate

C15H20Cl2N2O3 (346.0851)


   

3,5-dichloro-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-hydroxy-6-methoxybenzamide

3,5-dichloro-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-hydroxy-6-methoxybenzamide

C15H20Cl2N2O3 (346.0851)


   

SCHEMBL17867190

SCHEMBL17867190

C21H14O5 (346.0841)


   

Wailupemycin G

Wailupemycin G

C21H14O5 (346.0841)


   

Raclopride

Raclopride

C15H20Cl2N2O3 (346.0851)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Raclopride is a dopamine D2/D3 receptor antagonist with potential antipsychotic effects. Raclopride binds to D2 and D3 receptors with Kis of 1.8 nM and 3.5 nM, respectively[1][2].

   

Propylthiouracil glucuronide

Propylthiouracil glucuronide

C13H18N2O7S (346.0835)


   

(5R)-(+)-2,2,3-TRIMETHYL-5-BENZYL-4-IMIDAZOLIDINONE DICHLOROACETIC ACID

(5R)-(+)-2,2,3-TRIMETHYL-5-BENZYL-4-IMIDAZOLIDINONE DICHLOROACETIC ACID

C15H20Cl2N2O3 (346.0851)


   

(5S)-(-)-2,2,3-TRIMETHYL-5-BENZYL-4-IMIDAZOLIDINONE DICHLOROACETIC ACID

(5S)-(-)-2,2,3-TRIMETHYL-5-BENZYL-4-IMIDAZOLIDINONE DICHLOROACETIC ACID

C15H20Cl2N2O3 (346.0851)


   

Raclopride C 11

Raclopride C 11

C15H20Cl2N2O3 (346.0851)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate

   

(2s)-6-hydroxy-4,7'-dimethyl-6'-oxaspiro[1-benzofuran-2,2'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),4',7',9',11'-pentaene-3,3'-dione

(2s)-6-hydroxy-4,7'-dimethyl-6'-oxaspiro[1-benzofuran-2,2'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),4',7',9',11'-pentaene-3,3'-dione

C21H14O5 (346.0841)


   

6-(4,5-dihydroxy-2-phenylnaphthalen-1-yl)-4-hydroxypyran-2-one

6-(4,5-dihydroxy-2-phenylnaphthalen-1-yl)-4-hydroxypyran-2-one

C21H14O5 (346.0841)


   

6-hydroxy-4,7'-dimethyl-6'-oxaspiro[1-benzofuran-2,2'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),4',7',9',11'-pentaene-3,3'-dione

6-hydroxy-4,7'-dimethyl-6'-oxaspiro[1-benzofuran-2,2'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),4',7',9',11'-pentaene-3,3'-dione

C21H14O5 (346.0841)


   

2-(4,5-dihydroxy-2-phenylnaphthalen-1-yl)-6-hydroxypyran-4-one

2-(4,5-dihydroxy-2-phenylnaphthalen-1-yl)-6-hydroxypyran-4-one

C21H14O5 (346.0841)